Skip to main content
. 2022 May;43(5):682–688. doi: 10.3174/ajnr.A7477

Table 2:

Clinical and demographic summary for training and test set groupsa

Training Test
Diagnosis (GBM/NGG/Other) 24/4/1 8/6/1
Age (yr) 62.5 (12.9) 55.8 (14.5)
Overall survival (mo) 39.9 (69.5) 41.3 (44.9)
Radiation treatment (y/n) 25/4 14/1
Chemotherapy (y/n) 26/3 14/1
Tumor-treating fields (y/n) 12/17 4/11
Other treatment (y/n) 3/26 4/11
Time between last MR imaging and death (days) 46.2 (39.2) 95.5 (83.9)

Note:—Y/n indicates yes/no.

a

Quantitative values are presented as mean (SD).